Uju Obii-Obioha

Uju Obii-Obioha serves as a key procurement professional within the National Institute of Allergy and Infectious Diseases (NIAID), supporting the agency’s mission to accelerate biomedical solutions for infectious, immunologic, and allergic diseases. Responsible for managing complex research and development acquisitions, Obii-Obioha oversees contracts that enable critical advancements in biosafety infrastructure, diagnostic technologies, and medical countermeasures. Their portfolio primarily includes high-containment laboratory services, biotechnology R&D, and analytical instrumentation procurement, ensuring alignment with federal public health preparedness priorities and NIH strategic objectives. Obii-Obioha maintains consistent contracting relationships with Quality Biological, Inc. and GENOMIC LABS LTD, both of which provide specialized biological reagents, high-containment research support, and genomic analysis capabilities. These partnerships reflect a focus on vendors with proven expertise in biosafety level 3 and 4 environments, pathogen characterization, and diagnostic assay development. The contracting approach emphasizes technical compliance, regulatory adherence, and supply chain reliability, with a preference for established contractors possessing validated capabilities in high-risk biomedical environments. Set-aside preferences show a strong emphasis on open competition, with 87.5% of awards issued without socioeconomic set-asides. However, Obii-Obioha consistently allocates 12.5% of acquisitions to Total Small Business Set-Asides under FAR 19.5, demonstrating a measured commitment to small business participation without compromising technical requirements. This pattern reflects a balanced approach that prioritizes mission-critical performance while still fostering opportunities for qualified small firms in the biomedical sector. The primary NAICS focus areas include 541714 for biotechnology R&D, 334516 for analytical laboratory instrument manufacturing, and 541690/541990 for scientific consulting and technical services. Obii-Obioha’s expertise centers on procuring advanced diagnostics, biosafety equipment, and specialized research services essential to NIAID’s response to emerging pathogens and public health threats, ensuring that acquisitions align with cutting-edge scientific and regulatory standards.